|
ASX - By Stock
|
MSB |
Re:
R&D day
|
|
benelong
|
50 |
13K |
37 |
16/03/26 |
| 16/03/26 |
ASX - By Stock
|
50
|
13K
|
37
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Corporate Presentation and Half Year Financial Results
|
|
benelong
|
87 |
31K |
40 |
04/03/26 |
| 04/03/26 |
ASX - By Stock
|
87
|
31K
|
40
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Corporate Presentation and Half Year Financial Results
|
|
benelong
|
87 |
31K |
16 |
04/03/26 |
| 04/03/26 |
ASX - By Stock
|
87
|
31K
|
16
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
10 |
04/03/26 |
| 04/03/26 |
ASX - By Stock
|
21K
|
8.9M
|
10
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
13 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
20K
|
7.6M
|
13
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
14 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
21K
|
8.9M
|
14
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
68 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
21K
|
8.9M
|
68
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
35 |
02/03/26 |
| 02/03/26 |
ASX - By Stock
|
21K
|
8.9M
|
35
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
8 |
24/02/26 |
| 24/02/26 |
ASX - By Stock
|
20K
|
7.6M
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
86 |
17/02/26 |
| 17/02/26 |
ASX - By Stock
|
21K
|
8.9M
|
86
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
9 |
15/02/26 |
| 15/02/26 |
ASX - By Stock
|
21K
|
8.9M
|
9
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
17 |
15/02/26 |
| 15/02/26 |
ASX - By Stock
|
21K
|
8.9M
|
17
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
8 |
15/02/26 |
| 15/02/26 |
ASX - By Stock
|
20K
|
7.6M
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
13 |
15/02/26 |
| 15/02/26 |
ASX - By Stock
|
20K
|
7.6M
|
13
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
25 |
15/02/26 |
| 15/02/26 |
ASX - By Stock
|
20K
|
7.6M
|
25
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
15 |
13/02/26 |
| 13/02/26 |
ASX - By Stock
|
21K
|
8.9M
|
15
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: High Survival Rates with Ryoncil in SR-aGvHD EIND Program
|
|
benelong
|
112 |
33K |
11 |
12/02/26 |
| 12/02/26 |
ASX - By Stock
|
112
|
33K
|
11
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: High Survival Rates with Ryoncil in SR-aGvHD EIND Program
|
|
benelong
|
112 |
33K |
24 |
12/02/26 |
| 12/02/26 |
ASX - By Stock
|
112
|
33K
|
24
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
18 |
10/02/26 |
| 10/02/26 |
ASX - By Stock
|
21K
|
8.9M
|
18
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
13 |
03/02/26 |
| 03/02/26 |
ASX - By Stock
|
20K
|
7.6M
|
13
|
|
|
ASX - By Stock
|
MSB |
Re:
Valuing Mesoblast based on revenue
|
|
benelong
|
545 |
287K |
40 |
02/02/26 |
| 02/02/26 |
ASX - By Stock
|
545
|
287K
|
40
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
benelong
|
87 |
28K |
53 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
87
|
28K
|
53
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
benelong
|
87 |
28K |
29 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
87
|
28K
|
29
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Real World Experience with Ryoncil Shows 84% Early Survival
|
|
benelong
|
127 |
36K |
33 |
27/01/26 |
| 27/01/26 |
ASX - By Stock
|
127
|
36K
|
33
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
52 |
22/01/26 |
| 22/01/26 |
ASX - By Stock
|
20K
|
7.6M
|
52
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA meeting on Rexlemestrocel-L, CLBP and Opioid Cessation
|
|
benelong
|
389 |
126K |
36 |
16/01/26 |
| 16/01/26 |
ASX - By Stock
|
389
|
126K
|
36
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
2 |
13/01/26 |
| 13/01/26 |
ASX - By Stock
|
20K
|
7.6M
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
33 |
13/01/26 |
| 13/01/26 |
ASX - By Stock
|
20K
|
7.6M
|
33
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ryoncil Sales for the Quarter Increase 60% to US$35.1M
|
|
benelong
|
156 |
58K |
5 |
09/01/26 |
| 09/01/26 |
ASX - By Stock
|
156
|
58K
|
5
|
|
|
ASX - By Stock
|
MSB |
Re:
$3 Party
|
|
benelong
|
283 |
106K |
20 |
08/01/26 |
| 08/01/26 |
ASX - By Stock
|
283
|
106K
|
20
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
30 |
08/01/26 |
| 08/01/26 |
ASX - By Stock
|
20K
|
7.6M
|
30
|
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ Meso daily flow charts
|
|
benelong
|
738 |
293K |
3 |
06/01/26 |
| 06/01/26 |
ASX - By Stock
|
738
|
293K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
34 |
05/01/26 |
| 05/01/26 |
ASX - By Stock
|
21K
|
8.9M
|
34
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
18 |
17/12/25 |
| 17/12/25 |
ASX - By Stock
|
21K
|
8.9M
|
18
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
27 |
16/12/25 |
| 16/12/25 |
ASX - By Stock
|
21K
|
8.9M
|
27
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD
|
|
benelong
|
61 |
24K |
31 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
61
|
24K
|
31
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
13 |
10/12/25 |
| 10/12/25 |
ASX - By Stock
|
20K
|
7.6M
|
13
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
53 |
09/12/25 |
| 09/12/25 |
ASX - By Stock
|
20K
|
7.6M
|
53
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
18 |
09/12/25 |
| 09/12/25 |
ASX - By Stock
|
20K
|
7.6M
|
18
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
39 |
08/12/25 |
| 08/12/25 |
ASX - By Stock
|
20K
|
7.6M
|
39
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Participation at Piper Sandler Conference
|
|
benelong
|
78 |
32K |
2 |
05/12/25 |
| 05/12/25 |
ASX - By Stock
|
78
|
32K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Participation at Piper Sandler Conference
|
|
benelong
|
78 |
32K |
4 |
05/12/25 |
| 05/12/25 |
ASX - By Stock
|
78
|
32K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
2 |
04/12/25 |
| 04/12/25 |
ASX - By Stock
|
21K
|
8.9M
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
21K |
8.9M |
3 |
04/12/25 |
| 04/12/25 |
ASX - By Stock
|
21K
|
8.9M
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
20K |
7.6M |
2 |
03/12/25 |
| 03/12/25 |
ASX - By Stock
|
20K
|
7.6M
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
benelong
|
881 |
277K |
2 |
03/12/25 |
| 03/12/25 |
ASX - By Stock
|
881
|
277K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
benelong
|
881 |
277K |
3 |
03/12/25 |
| 03/12/25 |
ASX - By Stock
|
881
|
277K
|
3
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
benelong
|
3.2K |
1.3M |
14 |
01/12/25 |
| 01/12/25 |
ASX - By Stock
|
3.2K
|
1.3M
|
14
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
benelong
|
3.2K |
1.3M |
38 |
01/12/25 |
| 01/12/25 |
ASX - By Stock
|
3.2K
|
1.3M
|
38
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
benelong
|
3.2K |
1.3M |
8 |
30/11/25 |
| 30/11/25 |
ASX - By Stock
|
3.2K
|
1.3M
|
8
|
|